Author:
Wang Zheng,Zhou Jian,Fan Jia,Tan Chang-Jun,Qiu Shuang-Jian,Yu Yao,Huang Xiao-Wu,Tang Zhao-You
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference29 articles.
1. Blancher C, Moore JW, Robertson N, Harris AL (2001) Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxiainducible factor (HIF)-1 alpha, HIF-2 alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway. Cancer Res 61:7349–7355
2. Boffa DJ, Luan F, Thomas D, Yang H, Sharma VK, Lagman M et al (2004) Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer. Clin Cancer Res 10:293–300. doi: 10.1158/1078-0432.CCR-0629-3
3. Breier G, Blum S, Peli J, Groot M, Wild C, Risau W et al (2002) Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis. Int J Cancer 97:142–148. doi: 10.1002/ijc.1599
4. Burke B, Tang N, Corke KP, Tazzyman D, Ameri K, Wells M et al (2002) Expression of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxiaregulated cancer gene therapy. J Pathol 196:204–212. doi: 10.1002/path.1029
5. Chan S, Scheulen ME, Johnston S, Mross K, Cardoso F, Dittrich C et al (2005) Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer. J Clin Oncol 23:5314–5322. doi: 10.1200/JCO.2005.66.130
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献